Allspring Global Investments’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Allspring Global Investments's DGX Position: Q2 2026 in Review
Allspring Global Investments increased its Quest Diagnostics (DGX) stake by 3.6% in Q2 2026, buying an estimated $118K and bringing the position to 17,244 shares worth $3.73M. The position accounts for 0.01% of the portfolio, ranked #946.
Allspring Global Investments first reported a position in DGX in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.13M in Q2 2023. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Allspring Global Investments held 17,244 shares of Quest Diagnostics worth $3.73M as of Q2 2026.
- Allspring Global Investments bought 599 Quest Diagnostics shares in Q2 2026, an estimated $118K.
- Quest Diagnostics made up 0.01% of Allspring Global Investments's portfolio in Q2 2026, its #946 holding.
- Allspring Global Investments first reported a position in Quest Diagnostics in Q4 2021 and has held it in 19 quarters since.
- Allspring Global Investments's Quest Diagnostics position peaked at $4.13M in Q2 2023.
- 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.